Prior TIA, lipid-lowering drug use, and physical activity decrease ischemic stroke severity

Neurology

Volumn 67, Issue 8, 2006, Pages 1403-1410

  Deplanque, D ^a,b   Masse, I ^a,b   Lefebvre, C ^a   Libersa, C ^a,b   Leys, D ^a   Bordet, R ^a  

^a UNIV LILLE   (France)

^b University of Lille   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; ANTIDEPRESSANT AGENT; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; ANXIOLYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FIBRIC ACID DERIVATIVE; FIBRINOGEN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; HYPNOTIC AGENT; INSULIN; NITRIC ACID DERIVATIVE; ORAL ANTIDIABETIC AGENT; ORAL CONTRACEPTIVE AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; BARTHEL INDEX; BLOOD PRESSURE; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GLUCOSE BLOOD LEVEL; HORMONE SUBSTITUTION; HOSPITAL ADMISSION; HUMAN; LEISURE; MAJOR CLINICAL STUDY; MALE; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RANKIN SCALE; TEMPERATURE; TRANSIENT ISCHEMIC ATTACK; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTILIPEMIC AGENTS; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; ISCHEMIC ATTACK, TRANSIENT; LEISURE ACTIVITIES; MALE; MEDICAL RECORDS; MIDDLE AGED; MOTOR ACTIVITY; OUTCOME ASSESSMENT (HEALTH CARE); SEVERITY OF ILLNESS INDEX;

EID: 33750283385     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.wnl.0000240057.71766.71     Document Type: Article

References (45)

1. Dirnagl U, Simon RP, Hallenbeck JM. Ischemic tolerance and endogenous neuroprotection. Trends Neurosci 2003;26:248-254.
2. Puisieux F, Deplanque D, Pu Q, et al. Differential role of nitric oxide pathway and heat shock protein in preconditioning and lipopolysaccharide-induced brain ischemic tolerance. Eur J Pharmacol 2000;389:71-78.
3. Wiegand F, Liao W, Busch C, et al. Respiratory chain inhibition induces tolerance to focal cerebral ischemia. J Cereb Blood Flow Metab 1999;19:1229-1237.
4. Bordet R, Deplanque D, Maboudou P, et al. Increase in endogenous brain superoxide dismutase as a potential mechanism of lipopolysaccharide-induced brain ischemic tolerance. J Cereb Blood Flow Metab 2000;20:1190-1196.
5. Endres M, Laufs U, Huang Z, et al. Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase. Proc Natl Acad Sci USA 1998;95:8880-8885.
6. Vaughan CJ, Delanty N. Neuroprotective properties of statins in cerebral ischemia and stroke. Stroke 1999;30:1969-1973.
7. Deplanque D, Gelé P, Pétrault O, et al. Peroxisome proliferator-activated receptor-alpha activation as a mechanism of preventive neuroprotection induced by chronic fenofibrate treatment. J Neurosci 2003;23:6264-6271.
8. Sadoshima S, Fujii K, Ooboshi H, Ibayashi S, Fujishima M. Angiotensin converting enzyme inhibitors attenuate ischemic brain metabolism in hypertensive rats. Stroke 1993;24:1561-1566.
9. Dai WJ, Funk A, Herdegen T, Unger T, Culman J. Blockade of central angiotensin AT(1) receptors improves neurological outcome and reduces expression of AP-1 transcription factors after focal brain ischemia in rats. Stroke 1999;30:2391-2398.
10. Fisher M, Jones S, Sacco RL. Prophylactic neuroprotection for cerebral ischemia. Stroke 1994;25:1075-1080.
11. Weih M, Kallenberg K, Bergk A, et al. Attenuated stroke severity after prodromal TIA: a role for ischemic tolerance in the brain? Stroke 1999;30:1851-1854.
12. Moncayo J, de Freitas GR, Bogousslavsky J, Altieri M, van Melle G. Do transient ischemic attacks have a neuroprotective effect? Neurology 2000;54:2089-2094.
13. Wegener S, Gottschalk B, Jovanovic V, et al., for the MRI in Acute Stroke Study Group of the German Competence Network Stroke. Transient ischemic attacks before ischemic stroke: preconditioning the human brain? A multicenter magnetic resonance imaging study. Stroke 2004;35:616-621.
14. Sitzer M, Foerch C, Neumann-Haefelin T, et al. Transient ischaemic attack preceding anterior circulation infarction is independently associated with favourable outcome. J Neurol Neurosurg Psychiatry 2004;75:659-660.
15. Schaller B. Ischemic preconditioning as induction of ischemic tolerance after transient ischemic attacks in human brain: its clinical relevance. Neurosci Lett 2005;377:206-211.
16. Jonsson N, Asplund K. Does pretreatment with statins improve clinical outcome after stroke? A pilot case-referent study. Stroke 2001;32:1112-1115.
17. Marti-Fabregas J, Gomis M, Arboix A, et al. Favorable outcome of ischemic stroke in patients pretreated with statins. Stroke 2004;35:1117-1123.
18. Greisenegger S, Müllner M, Tentschert S, Lang W, Lalouschek W. Effect of pretreatment with statins on the severity of acute ischemic cerebrovascular events. J Neurol Sci 2004;221:5-10.
19. Yoon SS, Dambrosia J, Chalela J, et al. Rising statin use and effect on ischemic stroke outcome. BMC Med 2004;2:1-7.
20. Moonis M, Kane K, Schwiderski U, Sandage BW, Fisher M. HMG-CoA reductase inhibitors improve acute ischemic stroke outcome. Stroke 2005;36:1298-1300.
21. Elkind MSV, Flint AC, Sciacca RR, Sacco RL. Lipid-lowering agent use at ischemic stroke onset is associated with decreased mortality. Neurology 2005;65:253-258.
22. Hénon H, Durieu I, Lebert F, Pasquier F, Leys D. Influence of prestroke dementia on early and delayed mortality in stroke patients. J Neurol 2003;250:10-16.
23. Aslanyan S, Fazekas F, Weir CJ, Horner S, Lees KR, GAIN International Steering Committee and Investigators. Effect of blood pressure during the acute period of ischemic stroke on stroke outcome: a tertiary analysis of the GAIN International Trial. Stroke 2003;34:2420-2425.
24. Reith J, Jorgensen HS, Pedersen PM, et al. Body temperature in acute stroke: relation to stroke severity, infarct size, mortality and outcome. Lancet 1996;347:422-425.
25. Kagansky N, Levy S, Knobler H. The role of hyperglycemia in acute stroke. Arch Neurol 2001;58:1209-1212.
26. Stummer W, Weber K, Tranner B, Baethmann A, Kempski O. Reduced mortality and brain damage after locomotor activity in gerbil forebrain ischemia. Stroke 1994;25:1862-1869.
27. Sacco RL, Gan R, Boden-Albala B, et al. Leisure-time physical activity and ischemic stroke risk. The Northern Manhattan Stroke Study. Stroke 1998;29:380-387.
28. Sacco RL, DeRosa JT, Haley EC Jr, et al., Glycine Antagonist in Neuroprotection Americas Investigators. Glycine antagonist in neuroprotection for patients with acute stroke: GAIN Americas: a randomized controlled trial. JAMA 2001;285:1719-1728.
29. Aslanyan S, Weir CJ, Johnston C, Lees KR, for the GAIN International Steering Committee and Investigators. Poststroke neurological improvement within 7 days is associated with subsequent deterioration. Stroke 2004;35:2165-2170.
30. Sulter G, Steen C, De Keyser J. Use of the Barthel index and modified Rankin scale in acute stroke trials. Stroke 1999;30:1538-1541.
31. Adams HP Jr, Bendixen BH, Kappelle LJ, et al., and the TOAST investigators. Classification of subtypes of acute ischemic stroke. Definitions for use in a multicenter clinical trial Stroke 1993;24:35-41.
32. Jorm AF, Korten AE. Assessment of cognitive decline in the elderly by informant interview. Br J Psychiatry 1988;152:209-213.
33. Bendel RB, Afifi AA. Comparison of stopping rules in forward regression. J Am Stat Assoc 1977;72:46-53.
34. Lee CD, Folsom AR, Blair SN. Physical activity and stroke risk: a meta-analysis. Stroke 2003;34:2475-2482.
35. Wendel-Vos GC, Schuit AJ, Feskens EJ, et al. Physical activity and stroke: a meta-analysis of observational data. Int J Epidemiol 2004;33:787-798.
36. Endres M, Gertz K, Lindauer U, et al. Mechanisms of stroke protection by physical activity. Ann Neurol 2003;54:582-590.
37. Ding Y, Li J, Luan X, et al. Exercise preconditioning reduces brain damage in ischemic rats that may be associated with regional angiogenesis and cellular overexpression of neurotrophin. Neuroscience 2004;124:583-591.
38. Ding YH, Young CN, Luan X, et al. Exercise preconditioning ameliorates inflammatory injury in ischemic rats during reperfusion. Acta Neuropathol 2005;109:237-246.
39. Johnston SC. Ischemic preconditioning from transient ischemic attacks? Data from the Northern California TIA Study. Stroke 2004;35(suppl I):2680-2682.
40. Belayev L, Ginsberg MD, Alonso OF, et al. Bilateral ischemic tolerance of rat hippocampus induced by prior unilateral transient focal ischemia: relationship to c-fos mRNA expression. Neuroreport 1996;20:55-59.
41. Yan B, Parsons M, McKay S, et al. When to measure lipid profile after stroke? Cerebrovasc Dis 2005;19:234-238.
42. Vauthey C, de Freitas GR, van Melle G, Devuyst G, Bogousslavsky J. Better outcome after stroke with higher serum cholesterol levels. Neurology 2000;54:1944-1949.
43. Hénon H, Godefroy O, Leys D, et al. Early predictors of death and disability after acute cerebral ischemic event. Stroke 1995;26:392-398.
44. Masse I, Bordet R, Deplanque D, et al. Lipid-lowering drugs are associated with a slower cognitive decline in patients with Alzheimer's disease. J Neurol Neurosurg Psychiatry 2005;76:1624-1629.
45. Herrmann N, Lanctot KL. Do atypical antipsychotics cause stroke? CNS Drugs 2005;19:91-103.